bromodeoxyuridine has been researched along with exenatide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Egan, JM; Greig, NH; Lahiri, DK; Perry, T; Shaw, KT; Zhou, J | 1 |
| Bernier, M; Doyle, ME; Egan, JM; Goetschkes, MM; Greig, NH; Holloway, HW; McConville, P; Spencer, RG; Theodorakis, MJ | 1 |
| Greig, NH; Holloway, HW; Li, Y; Mattson, MP; Tweedie, D | 1 |
| Byun, K; Choi, JH; Hwang, IK; Lee, B; Lee, CH; Li, H; Park, OK; Won, MH; Yan, BC; Yoo, KY | 1 |
| Bertilsson, G; Dannaeus, K; Isacson, R; Nielsen, E; Patrone, C; Wikström, L; Zachrisson, O | 1 |
5 other study(ies) available for bromodeoxyuridine and exenatide
| Article | Year |
|---|---|
A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.
Topics: Amino Acid Sequence; Animals; Antimetabolites; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Differentiation; Cyclic AMP; DNA Replication; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Immunohistochemistry; L-Lactate Dehydrogenase; Molecular Sequence Data; Nerve Growth Factor; Neurodegenerative Diseases; PC12 Cells; Peptide Fragments; Peptides; Protein Precursors; Rats; Receptors, Glucagon; Stimulation, Chemical; Tetrazolium Salts; Thiazoles; Venoms | 2002 |
In vivo biological activity of exendin (1-30).
Topics: Adipose Tissue; Amino Acid Sequence; Animals; Blood Glucose; Body Composition; Bromodeoxyuridine; Cell Proliferation; Diabetes Mellitus; Eating; Exenatide; Glycated Hemoglobin; Immunoenzyme Techniques; Injections, Intraperitoneal; Insulin; Islets of Langerhans; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microscopy, Confocal; Molecular Sequence Data; Peptides; Rats; Rats, Inbred F344; Venoms; Weight Gain | 2005 |
Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
Topics: Activating Transcription Factor 4; Adrenergic Agents; Apoptosis; bcl-2-Associated X Protein; Bromodeoxyuridine; Butadienes; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Neuroblastoma; Neuroprotective Agents; Nitriles; Oxidants; Oxidopamine; Peptides; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucagon; Signal Transduction; Time Factors; Transfection; Venoms | 2010 |
Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Dentate Gyrus; Doublecortin Domain Proteins; Doublecortin Protein; Exenatide; Ki-67 Antigen; Male; Mice; Mice, Inbred ICR; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Neuroprotective Agents; Peptides; Stem Cells; Venoms | 2010 |
The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test.
Topics: Affect; Animals; Behavior, Animal; Biomarkers; Bromodeoxyuridine; Cell Differentiation; Cognition; Dose-Response Relationship, Drug; Doublecortin Protein; Drug Synergism; Exenatide; Glucagon-Like Peptide-1 Receptor; Hippocampus; Male; Maze Learning; Memory; Neurons; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Swimming; Venoms | 2011 |